Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Terumo Cardiovascular Group history
Terumo Cardiovascular Group company history timeline
In 1999, the company acquired the CardioVascular Systems division of the 3M Co., a move that helped it strengthen its position in that worldwide market.
The company also launched two new products lines in 1999: coronary stents, the first to be manufactured in Japan, and two lines of prefilled syringes, a market that appeared certain to grow strongly in the coming years.
Since 1999, Terumo Cardiovascular has expanded its cardiac surgery product line to include vascular grafts, endoscopic vessel harvesting, and more.
In 2000, Terumo opened its newest production facility, in the Philippines, in order to produce syringes and other products to meet the surge in demand in the southeast Asian market.
Pharmaceutical products account for 23 percent and the largest share of Terumo's sales, which topped ¥176 billion ($1.39 billion) in 2001.
In 2001, the company reached an agreement with fellow Japanese company Tanabe Pharmaceuticals to launch and market a line of prefilled atropine sulfate syringes.
2001: The company forms a marketing agreement for a new line of prefilled syringes with Tanabe Pharmaceuticals.
Terumo continued to take steps to increase its position in the worldwide market, including the establishment in May 2002 of a dedicated sales and marketing subsidiary for its South and Central American operations.
2002 CAPIOX Baby RX™ (RX05) Neonatal Oxygenator launched Terumo Corporation acquired Vascutek Ltd., a global leader in artificial vascular grafts
2005 Terumo Corporation became number one in the global perfusion products market and began to expand its portfolio to new product categories in the cardiac operating room VirtuoSaph™ Endoscopic Vein Harvesting System launched
2007 Terumo Cardiovascular Systems became the exclusive distributor of Vascutek® Vascular Grafts in the United States
2008 CAPIOX® FX Oxygenator, the industry’s first oxygenator with an integrated arterial filter, introduced CAPIOX® FX05 Oxygenator, the industry’s first pediatric oxygenator with an integrated arterial filter, launched
2011 Terumo Corporation acquired Harvest Technologies Corporation, a leader in the development of point-of-care cell therapy
2013 Terumo Cardiovascular Group formed, creating a global headquarters focused on the needs of cardiac surgery teams worldwide.
2019 Capiox® NX19 Oxygenator with UltraPrime™ Technology introduced, Terumo’s smallest full-size adult oxygenator to date.
2020 Terumo Cardiovascular Group updates name to Terumo Cardiovascular and introduces new logo, to focus on its market and customers.
Rate Terumo Cardiovascular Group's efforts to communicate its history to employees.
Terumo Cardiovascular Group jobs
Do you work at Terumo Cardiovascular Group?
Does Terumo Cardiovascular Group communicate its history to new hires?
Terumo Cardiovascular Group competitors
| Company name | Founded date | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Cardiac Pacemakers, Inc | 1971 | $1.4B | 2,500 | - |
| Edwards Lifesciences | 1958 | $5.4B | 14,000 | 542 |
| Thoratec Corporation | 1976 | $477.6M | 1,048 | - |
| Halyard Health | 2014 | $1.6B | 11,000 | - |
| Kensey Nash | 1984 | $80.4M | 200 | - |
| Welch Allyn | 1915 | $940.0M | 2,602 | - |
| NxStage Medical | 1998 | $393.9M | 3,800 | - |
| Ethicon | 1915 | $4.9B | 11,000 | - |
| Advanced Bionics | 1993 | - | 990 | - |
| Terumo Medical | 1972 | $4.3B | 23,319 | 79 |
Terumo Cardiovascular Group history FAQs
Zippia gives an in-depth look into the details of Terumo Cardiovascular Group, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Terumo Cardiovascular Group. The employee data is based on information from people who have self-reported their past or current employments at Terumo Cardiovascular Group. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Terumo Cardiovascular Group. The data presented on this page does not represent the view of Terumo Cardiovascular Group and its employees or that of Zippia.
Terumo Cardiovascular Group may also be known as or be related to Terumo Cardiovascular Group, Terumo Cardiovascular Systems and Terumo Cardiovascular Systems Corporation.